Nuvectis Pharma Statistics Share Statistics Nuvectis Pharma has 20.89M
shares outstanding. The number of shares has increased by 12.01%
in one year.
Shares Outstanding 20.89M Shares Change (YoY) 12.01% Shares Change (QoQ) -10.68% Owned by Institutions (%) 10.27% Shares Floating 13.84M Failed to Deliver (FTD) Shares 3,018 FTD / Avg. Volume 1.72%
Short Selling Information The latest short interest is 2.64M, so 12.66% of the outstanding
shares have been sold short.
Short Interest 2.64M Short % of Shares Out 12.66% Short % of Float 24.47% Short Ratio (days to cover) 30.27
Valuation Ratios The PE ratio is -4.87 and the forward
PE ratio is -5.5.
Nuvectis Pharma's PEG ratio is
0.22.
PE Ratio -4.87 Forward PE -5.5 PS Ratio 0 Forward PS 52.7 PB Ratio 9.53 P/FCF Ratio -7.56 PEG Ratio 0.22
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Nuvectis Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.09,
with a Debt / Equity ratio of 0.
Current Ratio 2.09 Quick Ratio 2.09 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.46M Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -2.86% in the
last 52 weeks. The beta is -0.27, so Nuvectis Pharma's
price volatility has been lower than the market average.
Beta -0.27 52-Week Price Change -2.86% 50-Day Moving Average 7.95 200-Day Moving Average 7.58 Relative Strength Index (RSI) 27.09 Average Volume (20 Days) 175,070
Income Statement
Revenue n/a Gross Profit n/a Operating Income -19.85M Net Income -19M EBITDA -19M EBIT -19M Earnings Per Share (EPS) -1.11
Full Income Statement Balance Sheet The company has 18.53M in cash and 0 in
debt, giving a net cash position of 18.53M.
Cash & Cash Equivalents 18.53M Total Debt n/a Net Cash n/a Retained Earnings -73.25M Total Assets 27.01M Working Capital 16.87M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.25M
and capital expenditures 0, giving a free cash flow of -12.25M.
Operating Cash Flow -12.25M Capital Expenditures n/a Free Cash Flow -12.25M FCF Per Share -0.72
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
